Adamas Pharmaceuticals/ US00548A1060 /
- - | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
-USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | - | - |
GlobeNewswire
1/4
Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Offi...
GlobeNewswire
10/10/2023
Zevra Therapeutics Appoints Neil F. McFarlane as President, Chief Executive Officer and Director
GlobeNewswire
3/2/2022
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2/28/2022
Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2/22/2022
Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer
GlobeNewswire
11/23/2021
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmac...
GlobeNewswire
10/28/2021
Moore Kuehn Encourages PSXP, BRPM, HFC, and ADMS Investors to Contact Law Firm
GlobeNewswire
10/27/2021
ADAMAS ALERT: Bragar Eagel & Squire, P.C. Announces Commencement of Tender Offer and Encourages Inve...
GlobeNewswire
10/21/2021
Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMD
GlobeNewswire
10/18/2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, AZPN, GSKY, GWB; Shareholders are Enc...
GlobeNewswire
10/14/2021
ADAMAS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ADMS and Encourages Investors to Cont...
GlobeNewswire
10/12/2021
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, AZPN, CXP; Shareholders are Enc...
GlobeNewswire
10/12/2021
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Adamas Pharmaceuticals, Inc. Merge...
GlobeNewswire
10/11/2021
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
GlobeNewswire
1/13/2021
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Driver...
GlobeNewswire
12/2/2020
Osmotica Pharmaceuticals plc Announces Agreement to Settle Patent Litigation with Adamas